Cancer cachexia-pathophysiology and management

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.48, Iss.5, 2013-05, pp. : 574-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer cachexia as a model for treatment of obesity

By Raman P.

International Journal of Diabetes in Developing Countries, Vol. 32, Iss. 1, 2012-03 ,pp. : 61-61

Springer Publishing Company

Access to resources Recommend Favorite

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 197-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Febuxostat improves outcome in a rat model of cancer cachexia

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 2, 2015-06 ,pp. : 174-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hyperprolactinemia: Pathophysiology and Management

By Verhelst J. Abs R.

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 23-32

Adis International

Access to resources Recommend Favorite

The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 157-170

Bentham Science Publishers

Access to resources Recommend Favorite